InMode (INMD) Return on Sales (2018 - 2026)

InMode (INMD) posted Return on Sales of 0.0% for Q1 2026, down 58.83% sequentially from 0.0% in Q4 2025, and little changed YoY from 0.0% in Q1 2025.

InMode (INMD) Return on Sales (2018 - 2026) Analysis & Trends

InMode has reported Return on Sales for 9 years, with the latest figure at 0.0% in Q1 2026.

Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Sales slipped to 0.0% in Q1 2026 per INMD's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 0.0% in Q4 2024.
A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
The sharpest annual moves came in 2024 and 2025: Return on Sales decreased 1 bps in 2024, then rose 1 bps in 2025.
Over 5 years, Return on Sales stood at 0.0% in 2022, then jumped by 82 bps to 0.01% in 2023, then slumped by 136 bps to 0.0% in 2024, then soared by 283 bps to 0.0% in 2025, then plunged by 59 bps to 0.0% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	0.00%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	0.00%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	0.00%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	0.00%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	0.00%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	0.00%
10	InMode	921.69 Mn	506.52 Mn	71.52 Mn	0.00%

Download Data